electroCore, Inc. Sustainability Profile
electroCore, Inc., a pioneering medical technology company headquartered in the United States, focuses on non-invasive neuromodulation therapies. Founded in 2014, the company has made significant strides in the treatment of various neurological conditions, particularly through its flagship product, gammaCore. This innovative device is designed to deliver electrical stimulation to the vagus nerve, offering a unique approach to managing conditions such as cluster headaches and migraine. With a strong presence in North America and expanding operations in Europe, electroCore has established itself as a leader in the neuromodulation industry. The company’s commitment to research and development has led to notable achievements, including FDA approvals and clinical studies that underscore the efficacy of its therapies. As a result, electroCore continues to enhance patient care and redefine treatment paradigms in neurology.
DitchCarbon Score
How does electroCore, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
electroCore, Inc.'s score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
electroCore, Inc.'s reported carbon emissions
As of the latest available data, electroCore, Inc. has not reported any specific carbon emissions figures. However, the company has made significant climate commitments through the Science Based Targets initiative (SBTi). electroCore, Inc. aims to reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2023 as the baseline year. This target is part of a broader commitment to measure and reduce its Scope 3 emissions as well. These targets are classified as "absolute" and are aligned with the necessary reductions to limit global warming to 1.5°C, reflecting the company's dedication to addressing climate change effectively. The targets were approved through a streamlined validation route specifically designed for small and medium-sized enterprises (SMEs), indicating a structured approach to sustainability. Overall, while specific emissions data is currently unavailable, electroCore, Inc.'s commitment to substantial GHG reductions positions it as a proactive player in the fight against climate change.
How Carbon Intensive is electroCore, Inc.'s Industry?
How Carbon Intensive is electroCore, Inc.'s Location?
electroCore, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
electroCore, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Horizon Therapeutics Public Limited Company
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.